A Pennsylvania whistleblower's allegations of corrupt sales practices in the pharmaceuticals industry have resulted in more than $1.2 billion in settlements with Uncle Sam -- and rewards of more than $110 million to the whistleblower. AstraZeneca Inc. announced Friday that it had agreed to pay nearly $280 million in civil penalties and an additional criminal fine of more than $63 million to resolve allegations of Medicare fraud.
Pharmaceutical Companies to Pay $1.2B in Medicare Fraud
The Legal Intelligencer
June 24, 2003
This article requires premium access
This article requires premium access to Law.com. Please sign in or subscribe to read the full text.